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Abstract
Background: During the onset of osteoarthritis (OA), certain biochemical events have been shown to accelerate
cartilage degradation, including the dysregulation of cartilage ECM anabolism, abnormal generation of reactive
oxygen species (ROS) and overproduction of proteolytic enzymes and inflammatory cytokines. The potency of
aucubin in protecting cellular components against oxidative stress, inflammation and apoptosis effects are well
documented, which makes it a potential candidate for OA treatment. In this study, we aimed to evaluate the
protective benefits of aucubin against OA using H2O2 and compression induced OA-like chondrocyte models.
Methods: The effects of aucubin were studied in porcine chondrocytes after 1 mM H2O2 stimulation for 30 min or
sustained compression for 24 h. Effects of aucubin on cell proliferation and cytotoxicity of chondrocytes were
measured with WST-1 and LDH assays. ROS production was evaluated by the Total ROS/Superoxide Detection
Kit. Caspase-3 activity was evaluated by the CaspACE assay system. The levels of apoptosis were evaluated by
the Annexin V-FITC apoptosis detection kit. OA-related gene expression was measured by reverse transcription
quantitative polymerase chain reaction (RT-qPCR). Total DNA quantification was evaluated by the DNeasy Blood and
Tissue kit. Sulfated-glycosaminoglycans (sGAGs) production and content were evaluated by DMMB assay and Alcian
blue staining.
Results: The results showed that the ROS scavenge effects of aucubin appeared after 1 h of pretreatment. Aucubin
could reduce the caspase-3 activity induced by H2O2, and reduced the apoptosis cell population in flowcytometry. In
RT-qPCR results, aucubin could maintain ACAN and COL2A1 gene expressions, and prevent IL6 and MMP13 gene up-
regulation induced by H2O2 and compression stimulations. In the DMMB assay and Alcian blue staining, aucubin could
maintain the sGAG content and protect chondrocytes against compressive stress, but not oxidative stress from H2O2.
Conclusions: These results indicated that aucubin has protective effects in an osteoarthritic chondrocyte model
induced by H2O2 and mechanical stimulus.
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Background
Osteoarthritis (OA) is the most common form of arthritis
and the leading cause of disability in people over 65 years
old [1, 2]. The high prevalence rate among the elderly
makes it a considerable clinical and economic burden be-
cause of reduced quality of life and increased use of health
care resources [3, 4]. OA involves the entire joint, includ-
ing the subchondral bone, ligaments, periarticular muscle
and synovium, and is associated with risk factors, such as
age, gender, prior joint injury, obesity, genetic predispos-
ition and mechanical stress [5, 6]. In healthy individuals,
synthesis and degradation of cartilage extracellular matrix
(ECM) maintains a particular balance. However, this
homeostatic balance can be disrupted in OA cartilage by
reduced anabolic and increased catabolic capacities of
chondrocytes. Chondrocytes are the unique cells of the ar-
ticular cartilage ECM and are responsible for the synthesis
and degradation of the cartilage, which mainly consists of
type II collagen and sulfated proteoglycans (sGAG) [7].
During the initiation of OA, biochemical events have been
shown to accelerate the cartilage degradation, including
the dysregulation of the ECM anabolism, abnormal gener-
ation of reactive oxygen species (ROS) and overproduc-
tion of proteolytic enzymes and inflammatory cytokines
[8–10]. Disruption of homeostasis decreases type II colla-
gen and sGAG and leads to the loss of cellularity via apop-
tosis, which plays a central role in the caspase proteolytic
cascade, all of which is evident in the OA cartilage [11].
Damage from mechanical stress with insufficient self-
repair by joints is believed to be the primary cause of
OA. Excessive compressive stress can increase the pro-
duction of ROS in chondrocytes, which is sufficient to
depolymerize hyaluronic acid of ECM [12] or even kill
chondrocytes [13]. In response to mechanical loading
of articular cartilage, chondrocytes exhibit the same
changes in gene expression as those during OA, such
as upregulation of the matrix metalloproteinase 13 gene
(MMP13) and a disintegrin and metalloproteinase with
thrombospondin motifs (ADAMTS) gene family. There-
fore, cartilage explants stimulated with mechanical stresses
have been used as typical experimental models [14].
Several studies have shown that ROS, such as super-
oxide anions, hydroxyl radicals and hydrogen peroxide
(H2O2), play a role in cartilage degeneration [15, 16]. A
high-level of ROS production commonly results in apop-
tosis and senescence of the chondrocytes, and thus associ-
ates with a decreased number of chondrocytes and altered
cell phenotypes during OA [17]. H2O2 is a potent medi-
ator of membrane lipid peroxidation. The disruption of
mitochondrial membrane integrity caused by H2O2 leads
to the release of caspases that play essential roles in apop-
tosis [18]. Thus, H2O2 is frequently used as an inducer of
oxidative stress to investigate the role of cellular antioxi-
dants, like vitamin E, in ameliorating cellular injury [19].
In our previous studies, we have found that antioxi-
dants from Chinese herbal medicines have potential ben-
efits in long-term treatments of ROS-mediated diseases
[20]. Aucubin, an iridoid glucoside isolated from various
plants including leaves of Aucuba japonica and Eucom-
mia ulmoides [21, 22], has proven to possess numerous
pharmacological effects [23–25]. The potential role of
aucubin in protecting cellular components against oxida-
tive stress and inflammatory responses is well docu-
mented [26, 27]. However, the effect of aucubin on the
catabolic responses of chondrocytes or its therapeutic
role in OA has not been identified.
In this study, we investigated the effects of aucubin on
the following gene expressions: ECM-related genes
(COL2A1 and ACAN), the catabolic MMP13 gene and
the proinflammatory cytokine IL6 gene. The effect of
aucubin on ROS production, caspase-3 activity, chon-
drocyte apoptosis, cell proliferation activity and cytotox-
icity, sGAG production and sGAG content were also
investigated. Finally, we discuss the potential utility of
aucubin as a treatment for OA in light of our findings.
Methods
Isolation of chondrocytes
The isolation and use of porcine chondrocytes were ap-
proved by the Animal Experimentation Ethics Committee
of National Taiwan University Hospital. Fresh porcine sti-
fles were purchased from a traditional market and kept in-
tegrated till chondrocytes were isolated under aseptic
conditions. A total of 12 porcine stifles were used for all
experiments. Porcine chondrocytes were isolated from
macroscopically normal cartilage of the femoral condyles
[28]. Finely diced cartilage pieces were treated with 10%
antibiotics (15240-062, Gibco, USA) in phosphate buffered
saline (PBS) at 37 °C for 10 min, then re-suspended in
Dulbecco’s modified eagle’s medium (DMEM; D5648,
Sigma, USA) containing 10% fetal bovine serum (12003C,
SAFC, USA), 1% penicillin and 0.05% L-Ascorbic acid
(A5960, Sigma, USA) and 0.2% collagenase (C0130, Sigma,
USA) at 37 °C for 18 h. Chondrocytes were then collected
and washed twice with PBS, and cultured in DMEM.
Chondrocytes with a passage number of 2 to 4 were used
in all experiments.
Cell proliferation and cytotoxicity of aucubin on
chondrocytes
Chondrocytes were seeded in 96-well cell culture plates
at a density of 1 × 104 cells per well and cultured in
DMEM for 18 h. Cells were then cultured in the
medium containing 3, 10, 30, 100 μM aucubin (55561,
Sigma, USA). To evaluate the cell proliferation activity
of aucubin on chondrocytes, WST-1 assay (Cell Prolifer-
ation Reagent WST-1; Roche, Germany) was performed
on days 1 and 3. The OD value was measured at 450 nm
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using the enzyme-linked immunosorbent assay (ELISA)
reader (Sunrise, Tecan, Switzerland).
The LDH assay (CytoTox96 Non-Radioactive Cytotox-
icity Assay; Promega, USA) was performed on days 1
and 3 to evaluate the cytotoxicity of aucubin. LDH re-
leased in the culture supernatants was measured with a
30-min coupled enzymatic assay and measured using the
ELISA reader at a wavelength of 490 nm. The percent-
age of cytotoxicity was calculated using the following
equation:
Cytotoxicity %ð Þ ¼ ODexp − ODmedium
ODtotal lysis − ODmedium
 100
For both WST-1 and LDH assays, Chondrocytes de-
rived from more than three porcine stifles were used for
the experiments. Experiments were performed in five re-
peated measurements.
Aucubin pretreatment and induction of oxidative stress
The chondrocytes were seeded in 6-well cell culture
plates with a density of 1 × 105 cells per well, cultured in
DMEM with 10% fetal bovine serum (Gibco, USA) and
incubated overnight. Cells were pretreated with 100 μM
aucubin in full medium for 24 h. After washing once
with PBS, the oxidative stress was induced by introdu-
cing 1 mM H2O2 (RDH, USA) in full medium for
30 min, which was followed by a second PBS wash, and
then cultured in fresh medium at 37 °C for 24 h.
ROS scavenge effect
ROS production was evaluated by Total ROS/Superoxide
Detection Kit (ENZ-51010, Enzo Life Sciences, USA).
After H2O2 treatment, chondrocytes were collected,
washed twice with PBS and stained with 500 μl of the
ROS detection mix for 30 min in the dark, and then ana-
lyzed with an ELISA reader (Spectra Max, Molecular
Devices, USA). ROS fluorescence was also examined
using a confocal laser scanning biological microscope
(IX71/FV300, Olympus, Japan). Chondrocytes derived
from more than three porcine stifles were used for the
experiments. Experiments were performed in five re-
peated measurements.
Caspase-3 activity
Chondrocytes were collected after H2O2 treatment.
Total protein content was determined using a BCA pro-
tein assay kit (Pierce, USA) according to the manufac-
turer’s instructions. Caspase-3 activity was evaluated by
a CaspACE assay system (Promega, USA). Thirty micro-
gram of protein from each sample was mixed with a re-
action buffer containing 2 μl of DMSO, 10 μl of
100 mM DTT and 32 μl of caspase assay buffer in a 96-
well microplate. Two microlitre of DEVD-pNA was then
added and the proteins in solution were incubated at
37 °C for 4 h. The absorbance was measured at the
wavelength of 405 nm using an ELISA reader (Sunrise,
Tecan, Switzerland). Chondrocytes derived from more
than three porcine stifles were used for the experiments.
Five repeated measurements were performed for all
samples.
Chondrocyte apoptosis
The chondrocyte apoptosis was evaluated by Annexin
V-FITC apoptosis detection kit (ab14085, Abcam, USA).
At the end of aucubin pretreatment and H2O2 stimula-
tion, chondrocytes were collected, washed twice with
cold PBS and stained with 500 μl of the Annexin V-
FITC and PI mixed solution or 30 min in the dark, then
analyzed by flow cytometry (FC500, Beckman, USA).
Chondrocytes derived from more than three porcine sti-
fles were used for the experiments. Five repeated mea-
surements were performed for all samples.
Induction of compressive stress
The compressive stress was introduced with a custom-
made compressive device. We incorporated chondro-
cytes with chitosan-gelatin-glycerol phosphate hydrogel
as cell carrier [29]. The hydrogel incorporated chondro-
cytes were seeded into the wells of the compression de-
vice (200 μl/well) and cultured at 37 °C. After 24 h of
incubation, wells with cells were covered with polydi-
methylsiloxane membrane. The compression was given
via nitrogen gas with pressure of 60 psi, which com-
pressed the cells through the structural depression of
membrane, and chondrocytes were subjected to sus-
tained compression for 24 h. Chondrocytes without
treatment were used as control group.
RNA extraction and gene expression of chondrocytes
The chondrocytes were collected and total RNA was ex-
tracted using RNeasy Protect Mini kit (74104, QIAGEN,
Germany). Total RNA yield and RNA quality were de-
tected by spectrophotometer (NanoDrop™ 2000, Thermo
Fisher Scientific, USA). RNA samples showed an A260/
280 ratio between 1.8~2.0 and an A260/230 ratio be-
tween 2.0~2.2 were used for reverse transcription quan-
titative polymerase chain reaction (RT-qPCR). The first
strand complementary DNA (cDNA) was synthesized
from RNA and SuperScript™ III First-Strand Synthesis
System (18080-051 Invitrogen, USA) according to the
instructions provided by the manufacturer. The volume
of the PCR Mix of single reaction was 20 μl containing
1 μl of primer solution, 9 μl of cDNA and 10 μl of 2×
TaqMan Universal PCR Master Mix (4304437, ABI,
USA). TaqMan Gene Expression Assays (Life Technol-
ogy, USA) were used for gene expression analysis. The
target genes of RT-qPCR are summarized in Table 1.
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RT-qPCR was performed using an ABI PRISM 7900HT
Sequence Detection System and Sequence Detection
Software 2.2.2. The target genes were normalized to the
glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
The relative mRNA expression of each target gene was
determined using the ΔΔCt method.
Total DNA quantification
After compression/H2O2 treatment, chondrocytes were
collected and total DNA was purified using the DNeasy
Blood and Tissue kit (69504, QIAGEN, Germany), fol-
lowing the instructions provided by the manufacturer.
Total DNA yield was quantified by an ultra violet/vis-
ible/near infrared (UV/VIS/NIR) spectrophotometer
(DU 7500, Beckman, USA) at the wavelength of 260 and
280 nm. The ratio of 260 to 280 nm was between 1.8
and 2.0.
Analysis of sGAG production
The sGAG production was evaluated in a DMMB
(341088, Sigma, USA) assay, as previously described
[29]. At the end of compression/H2O2 treatment, cells
were reseeded in 6-well cell culture plates and incubated
for 3 days. The culture medium of each sample was col-
lected and 40 μl of the supernatant of each sample trans-
ferred to a 96-well microplate, after which 250 μl of
DMMB solution was added. The DMMB-sGAG com-
plex product was examined by an ELISA reader (Sunrise,
TECAN, Switzerland) at the wavelength of 595 nm. The
sGAG production activity of each sample was deter-
mined using a calibration curve of condroitin-6-sulfate
(C4384, Sigma, USA). The sGAG production was nor-
malized to cell numbers by a total DNA assay (sGAG to
DNA ratio). Chondrocytes derived from more than three
porcine stifles were used for the experiments. Five re-
peated measurements were performed for all samples.
Alcian blue staining
After compression/H2O2 treatment, cells were reseeded
into 4-well chamber-slides and cultured for 3 days.
Chondrocytes were washed twice with PBS and fixed in
10% neutral buffered formalin (H121-08, Mallinckrodt
Analytical, USA) for 30 min and then washed twice with
PBS. Alcian blue (pH 1.0, Muto pure chemicals, Japan)
was added for 30 min and cells were then washed in
running water for 1 min. Nuclear fast red (1001210500,
Merck, Germany) was added for 5 min and then washed
in running water for 1 min. The cells were dehydrated
in 2 changes of 95% alcohol and absolute alcohol
(459844, Sigma, USA) for 1 min each. The sGAG con-
tent images were taken by using an IX71 inverted micro-
scope equipped with a DP30BW digital camera system
(Olympus, Japan). Chondrocytes derived from more than
three porcine stifles were used for the experiments. Five
repeated measurements were performed for all samples.
Statistical analysis
The normality of variance of data was tested before stat-
istical analysis. Statistically significant differences be-
tween the groups were determined by one-way ANOVA
with Tukey’s post-hoc test. The results were expressed as
mean ± standard deviation of the mean (SD) and consid-
ered significant when the P-value was <0.05. Statistical
analysis was performed using the SigmaPlot version 12.3
software (Systat Software Inc., San Jose, USA).
Results
Aucubin shows no cytotoxic effects on chondrocytes
As shown in Fig. 1, chondrocytes treated with 3, 10, 30,
and 100 μM of aucubin showed no significant differ-
ences in cytotoxicity or cell proliferation activity com-
pared to controls at 1 or 3 days, indicating that aucubin
within the concentration range of 3–100 μM shows no
significant cytotoxic effects on chondrocytes at either 1
or 3 days.
Aucubin inhibits H2O2-induced ROS production in
chondrocytes
As shown in Fig. 2, the ROS production was significantly
increased in response to H2O2 stimulation. Chondro-
cytes treated with aucubin showed significant ROS scav-
enging effects after 1, 4 and 24 h of incubation with 10
to 100 μM aucubin in a dose-dependent manner. The
ROS scavenge effect of aucubin was further confirmed
through fluorescence imaging. As shown in Fig. 3, both
the green and red fluorescence emissions, representing
general ROS and superoxide induced by H2O2, respect-
ively, were markedly reduced in fluorescence intensity
and area after 24 h of 100 μM aucubin pretreatment.
Since 100 μM aucubin showed the greatest scavenging
effect with limited cytotoxicity among other aucubin
concentrations, we used 100 μM aucubin in the subse-
quent experiments.
Aucubin inhibits H2O2-induced caspase-3 activity on
chondrocytes
After H2O2 treatment, the caspase-3 activity of chon-
drocytes showed a significant increase. However,
chondrocytes treated with aucubin and caspase inhibitor
Table 1 Primers used in this study
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Z-VAD-FMK markedly decreased the caspase-3 activity
caused by H2O2 stimulation (Fig. 4).
Aucubin inhibits H2O2-induced apoptosis and necrosis in
chondrocytes
After H2O2 treatment, the percentage of apoptotic and
necrotic chondrocytes were significantly increased
compared to the control group. However, in the aucu-
bin pretreated group, the percentages of chondrocytes in
both early and late apoptosis states were significantly
reduced compared to the H2O2 stimulated group
(Fig. 5, Table 2).
Aucubin reverses H2O2-mediated and compression-mediated
gene expression of ACAN and COL2A1 in chondrocytes
ACAN and COL2A1 are ECM related genes. As shown
in the H2O2 model of Fig. 6a and b, the expression of
both ACAN and COL2A1 was significantly down-
Fig. 2 ROS scavenge test of aucubin. Chondrocytes pretreated with 0, 3, 10, 30 and 100 μM of aucubin for 0.5, 1, 4 and 24 h were
stimulated with 1 mM H2O2 for 30 min. ROS production was measured by the intensity of the dye fluorescence and represented as
relative fluorescence unit (RFU). Results shown represent mean ± SD obtained from five repeated measurements. *p < 0.05 compared with
the control group. #p < 0.05 compared with the H2O2 group
Fig. 1 WST-1 and LDH tests of aucubin. Chondrocytes treated with 3, 10, 30 and 100 μM of aucubin for 1 and 3 days were examined with (a)
WST-1 for cell proliferation and (b) LDH for aucubin cytotoxicity. Chondrocytes without aucubin treatment were set as the control group. Results
shown represent mean ± SD obtained from five repeated measurements
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regulated in the H2O2-treated group compared to the
control group. However, pretreatment with aucubin re-
versed the expression of these genes back to the level of
the control group and showed marked up-regulation
compared to the H2O2-treated group. Similar results
were shown in the compression model. The expression
of both ACAN and COL2A1 was also markedly down-
regulated in the loading group, though the aucubin pre-
treated chondrocytes had a significant up-regulation of
both ECM component genes after compression stimula-
tion compared to the control group (Fig. 6c and d).
Aucubin reduces H2O2-mediated and compression-mediated
gene expression of MMP13 and IL6 in chondrocytes
MMP13 is a catabolic gene in cartilage ECM homeo-
stasis. As shown in Fig. 6e and g, in both H2O2 and
compression models, the expression of MMP13 was
up-regulated compared to the control group after
stimulation. However, treatment with aucubin before
H2O2 and compression stimulation maintained the
expression of MMP13 at a comparable level to the
control group. Similar results were shown in the
Fig. 3 Fluorescence imaging of ROS production. Chondrocytes pretreated with 100 μM of aucubin for 24 h were then stimulated with 1 mM
H2O2 for 30 min. The green and red colors are the fluorescence of general ROS (hydrogen peroxide, peroxynitrite, hydroxyl radicals, nitric oxide,
peroxy radical) and superoxide, respectively. Chondrocytes without aucubin nor H2O2 treatment were set as the control group. Scale bar = 100 μm.
(5 repeated measurements for each group)
Fig. 4 Effect of aucubin on caspase-3 activity. Chondrocytes pretreated
with 100 μM of aucubin or Z-VAD-FMK as caspase inhibitor for 24 h
were then stimulated with 1 mM H2O2 for 30 min. Chondrocytes
without aucubin nor H2O2 treatment were set as the control group.
Results shown represent mean ± SD obtained from five repeated
measurements. *p < 0.05 compared with the control group. #p < 0.05
compared with the H2O2 group
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expression of the proinflammatory gene IL6. As shown in
Fig. 6f and h, IL6 was up-regulated compared to the con-
trol group in both models after stimulation. Moreover, the
up-regulated IL6 expression was reversed to a similar level
as the control group with the pretreatment of aucubin.
Aucubin increases sGAG production in compression
model but not after H2O2 stimulation
As shown in Fig. 7a, the sGAG to DNA ratio for the
H2O2 treated group was significantly decreased com-
pared to the control group. Treatment with aucubin
showed no significant difference for the H2O2 treated
group. However, the decreased sGAG to DNA ratio in-
duced by compressive stress was significantly increased
compared to the compression group (Fig. 7b).
Aucubin increases the sGAG content after both H2O2 and
compression stimulation
As shown in Fig. 7c and d, the alcian blue staining was
positive in the control groups for both H2O2 and com-
pression models. The H2O2 treated group, on the con-
trary, showed few areas of blue color with shrinking cell
morphology. With aucubin pretreatment, some of the
chondrocytes could maintain sGAG content. Similar re-
sults were also evident in the compression model.
Discussion
Aucubin has significant antioxidant and radical scaven-
ging properties in both in vivo and in vitro models [30],
making it a potential therapeutic agent in oxidative
stress-induced diseases. Aucubin has been shown to re-
duce ROS formation, malondialdehyde levels and β-
galactosidase activity, and increase glutathione levels in
UVB-irradiated human skin fibroblasts [31]. To evalu-
ate the protective effects of aucubin in regards to OA,
first we generated an osteoarthritic cell model with por-
cine chondrocytes by using 1 mM H2O2, which de-
creased 60% of chondrocytes proliferation activity but
showed no significant or immediate cytotoxicity to un-
treated control (data not shown). In this study, 10–
100 μM of aucubin caused no significant cytotoxicity or
differences in cell proliferation activity after incubation
with chondrocytes at 1 or 3 days (Fig. 1). After H2O2
stimulation, 10–100 μM of aucubin was a sufficient
range to reduce ROS production dose-dependently
after at least 1 h of pretreatment (Fig. 2). Pretreatment
with 100 μM of aucubin also inhibited H2O2-induced
caspase-3 activity (Fig. 4). Xue et al. reported that aucu-
bin inhibited H2O2‐induced apoptosis in PC12 cells
through regulation of the endogenous oxidant–antioxi-
dant balance [27]. In this study, we confirmed the
apoptosis inhibition properties of aucubin via Annexin-
V/PI flow cytometry (Fig. 5). The percentage of apop-
totic cells was significantly reduced when 100 μM of
aucubin were used, which is consistent with the Xue et
al. study and suggests that aucubin protects chondro-
cytes from cell apoptosis which is often observed dur-
ing OA progression.
Fig. 5 Annexin V/PI test of aucubin. Chondrocytes pretreated with 100 μM of aucubin for 24 h were then stimulated with 1 mM H2O2 for 30 min.
Chondrocytes without aucubin nor H2O2 treatment were set as the control group. (5 repeated measurements for each group)
Table 2 Quantitative results of Annexin V/PI test of aucubin
Percentage of cell (%)
Normal Early apoptosis Late apoptosisi Necrosis
Control 89.7 ± 9.5 2.5 ± 4.6 5.0 ± 3.8 3.1 ± 1.8
H2O2 25.5 ± 7.3
a 29.4 ± 4.2a 32.2 ± 6.8a 14.3 ± 7.6a
H2O2 + aucubin 60.1 ± 10.4
a,b 15.4 ± 5.3a,b 15.8 ± 4.2a,b 10.7 ± 5.3
Results shown represent mean ± SD obtained from 5 repeated measurements. ap <0.05 compared with the control group. bp < 0.05 compared with the
H2O2 group
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Fig. 6 (See legend on next page.)
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Aggrecan and type II collagen are the main components
of chondrocyte ECM and provide cartilage with compres-
sive and tensile resistance, respectively. In the OA cartilage,
a loss of proteoglycans and decrease in type II collagen has
been observed, leading to defective integrity of the cartilage
[29]. In this study, both H2O2 and compressive loading
caused significant down-regulations of ACAN and
COL2A1, suggesting the stimulated chondrocytes were
undergoing a degeneration process with weakened anabolic
activity (Fig. 6). However, chondrocytes pretreated with
aucubin showed a protective effect by reversing the H2O2/
compression induced down-regulation of both ACAN and
COL2A1 genes, which may implicate that aucubin has a
beneficial effect on chondrocyte ECM production.
(See figure on previous page.)
Fig. 6 Gene expressions after stimulation. Gene expressions of COL2A1 (a, c), ACAN (b, d), MMP13 (e, g) and IL6 (f, h) were examined by RT-qPCR.
Chondrocytes pretreated with 100 μM of aucubin for 24 h were then stimulated with 1 mM H2O2 (a, b, e and f) for 30 min, or 60 psi compression
(c, d, g and h) for 24 h. Data from five independent biological replicates each with three technical replicates are expressed as fold change compared
to untreated control and shown represent mean ± SD. Each target gene was normalized to GAPDH. *p < 0.05 compared with the control
group. #p < 0.05 compared with the H2O2 or loading group
Fig. 7 sGAG production and Alcian blue staining of GAG contents after stimulation. The ratio of sulfated-GAG to DNA of chondrocytes after stimulated
with 1 mM H2O2 (a) for 30 min or compression (b) with 60 psi for 24 h. Alcian blue and nuclear fast red staining of the chondrocytes was performed
after stimulated with (c) 1 mM H2O2 for 30 min or (d) compression with 60 psi for 24 h. Scale bar = 50 μm. Results shown represent mean ± SD ob-
tained from five repeated measurements. *p < 0.05 compared with the control group. #p < 0.05 compared with the loading group
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The expression of pro-inflammatory IL-6 inhibits the
synthesis of aggrecan and is highly elevated in OA car-
tilage [32]. IL-6 expression directly contributes to the
inhibitory effect of aggrecan through the Notch recep-
tor [33], mediating induction of MMP-13 expression
[34]. MMP-13 is a catabolic factor for cartilage ECM
metabolism, degrading proteoglycans and type II colla-
gen [35, 36]. Aucubin has been shown to inhibit TNF-
alpha and IL-6 production in antigen-stimulated rat
basophilic leukemia-2H3 mast cells [37]. Aucubin also
has been demonstrated to reverse the increased gene
and protein expression of MMP13, iNOS and COX-2
induced by IL-1β stimulation in rat chondrocytes [38].
In this study, aucubin significantly reversed the elevated
gene expression of IL6 and MMP13 genes in the H2O2
and compression stimulated chondrocytes, consistently
demonstrating the anti-inflammatory and anti-catabolic
properties of aucubin in chondrocytes (Fig. 6).
About the single reference gene of GAPDH, in the
previous study we had examined the gene expression of
porcine chondrocytes and used GAPDH as reference
gene for RT-qPCR [28]. After analysis the GAPDH gene
showed a consistent Ct value among groups with differ-
ent treatment. In the present study, we used the same
method to isolate the porcine chondrocytes and ob-
served the same phenomenon of GAPDH expressions in
RT-qPCR results. The Ct values of GAPDH did not
show a noticeable difference among chondrocytes stimu-
lated with compression, H2O2, Aucubin or in control
group. We suggest that treatments used in the present
study did not affect the expression of GAPDH gene, thus,
we used GAPDH as the house keeping gene in this study.
In the degenerated cartilage, a decrease in the content
of chondroitin sulfate results in a decrease of water con-
tent that affects the capability of cartilage to absorb the
external stress [39]. In this study, H2O2 and compression
stimulation significantly reduced the sGAG production
activity and decreased sGAG content. Chondrocytes pre-
treated with aucubin succeeded to maintain its sGAG
content after both H2O2 and compression stimulation,
and recover its sGAG production activity after compres-
sion stimulation. However, aucubin failed to maintain
the sGAG production activity after H2O2 stimulation
(Fig. 7). According to these data, we suggest that the
protective effects of aucubin may be overwhelmed by
the oxidative stress of H2O2. The oxidative stress may
lead to decrease the sGAG production activity of chon-
drocytes. Nevertheless, aucubin still has beneficial ability
to maintain sGAG content of chondrocytes after H2O2
and compression stimulation.
Conclusions
This study demonstrated that aucubin can reduces
ROS production, caspase-3 activity, and cell apoptosis.
Aucubin can protect porcine chondrocytes from H2O2
and compression-induced dysregulation of COL2A1,
ACAN, IL6 and MMP13 gene expressions. Addition-
ally, aucubin helps porcine chondrocytes maintain
sGAG contents after H2O2 and compressive stimulation.
These results indicated that aucubin has protective effects
in an osteoarthritic chondrocyte model induced by H2O2
and mechanical stimulus.
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